Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

CVS returns Zepbound to drug plans

Digest more
 · 1d · on MSN
CVS returns Zepbound to drug plans after Lilly slashes price
More than 10 million US patients will regain easy access to Eli Lilly & Co.’s obesity shot Zepbound through insurance after CVS Health Corp. reversed a controversial decision to restrict it for certain drug plans.

Continue reading

 · 1d
CVS Caremark will cover Lilly's weight loss drug Zepbound again after patient backlash
 · 1d · on MSN
CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans
29d

Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket

Eli Lilly on Thursday reported first-quarter earnings and revenue that blew past estimates, as demand for its blockbuster ...
4d

Eli Lilly Just Got a Huge Vote of Confidence From Morgan Stanley -- and It's All About Mounjaro

The efficacy of Eli Lilly's new, still-in-development GLP-1 drug is gaining attention, but don't forget its older GLP-1 drugs ...
Morning Overview on MSN
2d

Eli Lilly’s new obesity pill just stripped 85 pounds off patients in a late-stage trial — the steepest weight loss ever logged without a needle

Participants in Eli Lilly’s TRIUMPH-1 trial lost an average of roughly 85 pounds on the highest dose of retatrutide, an ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
  • Privacy
  • Terms